LY-2624803

DB15092InvestigationalSmall molecule

LY-2624803 is under investigation in clinical trial NCT01236105 (Effect of Activated Charcoal and Time of Dose on the Pharmacokinetics of LY2624803 in Healthy Subject).

Mechanism: Pharmacologically active on Histamine H1 receptor
Curator reviewed
Formula / weight: C₂₂H₂₅N₃O₃ · 379.46 g/mol (avg)
Code names: LY-2624803

Resolves to

Compound

UNII63J9EQ81YCCAS879409-35-5

Structure

InChIKeyUEFWDVMEDFCHGW-UHFFFAOYSA-NSMILESCC(C)(CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=CC=CC=C12)C(O)=O

Targets

P35367HRH1

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with LY-2624803, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account